A global phase II randomized trial comparing oral taxane ModraDoc006/r to intravenous docetaxel in metastatic castration resistant prostate cancer von Vaishampayan, Ulka N., Keessen, Marianne, Dreicer, Robert, Heath, Elisabeth I., Buchler, Tomas, Árkosy, Péter F., Csöszi, Tibor, Wiechno, Pawel, Kopyltsov, Evgeny, Orlov, Sergey V., Plekhanov, Alexey, Smagina, Maria, Varlamov, Sergei, Shore, Neal D.

Volltext

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma von Rini, Brian I, Plimack, Elizabeth R, Stus, Viktor, Gafanov, Rustem, Hawkins, Robert, Nosov, Dmitry, Pouliot, Frédéric, Alekseev, Boris, Soulières, Denis, Melichar, Bohuslav, Vynnychenko, Ihor, Kryzhanivska, Anna, Bondarenko, Igor, Azevedo, Sergio J, Borchiellini, Delphine, Szczylik, Cezary, Markus, Maurice, McDermott, Raymond S, Bedke, Jens, Tartas, Sophie, Chang, Yen-Hwa, Tamada, Satoshi, Shou, Qiong, Perini, Rodolfo F, Chen, Mei, Atkins, Michael B, Powles, Thomas

Volltext

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma von Choueiri, Toni K., Powles, Thomas, Peltola, Katriina, de Velasco, Guillermo, Burotto, Mauricio, Suarez, Cristina, Ghatalia, Pooja, Iacovelli, Roberto, Lam, Elaine T., Verzoni, Elena, Gümüş, Mahmut, Stadler, Walter M., Kollmannsberger, Christian, Melichar, Bohuslav, Venugopal, Balaji, Gross-Goupil, Marine, Poprach, Alexandr, De Santis, Maria, Schutz, Fabio A., Park, Se Hoon, Nosov, Dmitry A., Porta, Camillo, Lee, Jae Lyun, Garcia-del-Muro, Xavier, Biscaldi, Elisa, Manneh Kopp, Ray, Oya, Mototsugu, He, Li, Wang, Aobo, Perini, Rodolfo F., Vickery, Donna, Albiges, Laurence, Rini, Brian

Volltext